EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants

Maren Mynarek iD, Torstein Vik, Guro L Andersen, Anne K Brigtsen, Sandra Julsen Hollung iD, Tricia L Larose, Stian Lydersen, Lene C Olsen, Marianne S Strøm, Jan E Afset

Developmental Medicine & Child Neurology · 2024-01 · 66 (1) · 125-133

DOI: 10.1111/dmcn.15643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 12.06.2023. Verfasst von Maren Mynarek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Hauptthemen laut MEDLINE: Cerebral Palsy, Streptococcal Infections, Infant, Newborn, Diseases, Meningitis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess case fatality rate (CFR), infant mortality, and long‐term neurodevelopmental disorders (NDDs) after invasive group B streptococcal (GBS; Streptococcus agalactiae ) infection in infants.

Method

Children born in Norway between 1996 and 2019 were included. Data on pregnancies/deliveries, GBS infection, NDDs, and causes of death were retrieved from five national registries. The exposure was culture‐confirmed invasive GBS infection during infancy. Outcomes were mortality and NDDs, the latter at a mean age of 12 years 10 months.

Results

Among 1 415 625 live‐born children, 866 (87%) of 1007 infants diagnosed with GBS infection (prevalence 0.71 per 1000) were included. The CFR was 5.0% ( n = 43). GBS infection was associated with higher infant mortality (relative risk 19.41; 95% confidence interval [CI] 14.79–25.36) than the general population. Among survivors, 169 (20.7%) children were diagnosed with any NDD (relative risk 3.49; 95% CI 3.05–3.98). In particular, GBS meningitis was associated with high risks of attention‐deficit/hyperactivity disorder, cerebral palsy, epilepsy, hearing impairment, and pervasive and specific developmental disorder.

Interpretation

The burden of invasive GBS infection during infancy is considerable and continues to affect children beyond infancy. These findings emphasize the need for new preventive strategies for disease reduction, and the need for survivors to be directly included into early detection pathways to access early intervention if required. What this paper adds The burden of invasive group B streptococcal (GBS) infection in Norway is considerable. Of GBS infection survivors, 20.7% were diagnosed with neurodevelopmental disorders (NDDs) at mean age 12 years 10 months. Infants with GBS meningitis were more often diagnosed with NDDs. Absolute risks associated with GBS infections were highest for pervasive and specific developmental disorder, cerebral palsy, and attention‐deficit/hyperactivity disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral PalsyStreptococcal InfectionsInfant, Newborn, DiseasesMeningitisInfant, NewbornChildFemalePregnancyInfantHumansStreptococcus agalactiae

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Norwegian Quality and Surveillance Registry for Cerebral Palsy (NorCP), Vestfold Hospital Trust, Tønsberg, Norway.
  • Department of Neonatal Intensive Care, Clinic of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Health Registries, Division Digitalization and Health Registries, Norwegian Directorate of Health, Oslo, Norway.
  • Regional Centre for Child and Youth Health and Child Welfare, Norwegian University of Science and Technology, Trondheim, Norway.
  • BioCore Bioinformatics Core Facility, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

ORCID-Profile: Maren Mynarek, Sandra Julsen Hollung

Zitieren

APA

Mynarek, M., Vik, T., Andersen, G. L., Brigtsen, A. K., Hollung, S. J., Larose, T. L., Lydersen, S., Olsen, L. C., Strøm, M. S., & Afset, J. E. (2024). Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Developmental Medicine & Child Neurology, 66(1), 125-133. https://doi.org/10.1111/dmcn.15643

Vancouver

Mynarek M, Vik T, Andersen GL, Brigtsen AK, Hollung SJ, Larose TL, et al. Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Developmental Medicine & Child Neurology. 2024;66(1):125-133. doi:10.1111/dmcn.15643

BibTeX
@article{Mynarek2024,
  author = {Mynarek, Maren and Vik, Torstein and Andersen, Guro L and Brigtsen, Anne K and Hollung, Sandra Julsen and Larose, Tricia L and Lydersen, Stian and Olsen, Lene C and Strøm, Marianne S and Afset, Jan E},
  title = {Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants},
  journal = {Developmental Medicine & Child Neurology},
  year = {2024},
  volume = {66},
  number = {1},
  pages = {125--133},
  doi = {10.1111/dmcn.15643}
}
Kostenlos starten →